Drug Infusion Systems Market Analysis 2025–2029: Growth Forecast and Competitive Insights

Uncover key drivers, emerging technologies, and competitive movements shaping the drug infusion systems market from 2025–2034 with trusted insights from The Business Research Company

How Much Will The Drug Infusion Systems Market Be Worth By 2029, And What CAGR Will It Achieve?

The drug infusion systems market size has demonstrated robust expansion in recent years. This market is set to increase from $13.42 billion in 2024 to $14.23 billion in 2025, achieving a compound annual growth rate (CAGR) of 6.1%. This past growth can be ascribed to several factors, including the adoption of electronic infusion devices, a greater incidence of chronic diseases, developments in patient care, the rise of home-based infusion therapy, and the enlargement of ambulatory care settings.

The market size for drug infusion systems is projected to experience substantial expansion over the coming years. It is anticipated to reach $20.23 billion by 2029, achieving a compound annual growth rate (CAGR) of 9.2%. This anticipated growth during the forecast period can be attributed to several factors, including a move towards disposable systems, the increasing prevalence of chronic illnesses, the expansion of ambulatory care facilities, advancements in personalized medicine and adaptive dosing, and a growing need for home-based care. Key trends expected during this period encompass wireless connectivity and remote monitoring, the integration with electronic health records (EHR), the advent of smart pump technology, continued focus on personalized and adaptive dosing, and the development of minimally invasive infusion techniques.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10703&type=smp

Which Factors Are Driving The Drug Infusion Systems Market Forward?

The expanding occurrence of chronic illnesses is projected to fuel the expansion of the drug infusion system market moving ahead. Conditions like cancer, diabetes, cardiovascular ailments, and autoimmune disorders frequently necessitate prolonged or uninterrupted infusion treatment. These systems provide a secure, effective, and efficient method for delivering medicines to individuals suffering from such health issues. The prevalence has been rising at a faster rate in low- and middle-income countries compared to high-income nations. Diabetes significantly contributes to kidney failure, heart attacks, strokes, vision loss, and lower limb amputations. For example, in February 2024, data from the Centers for Disease Control and Prevention (CDC), a US-based entity, indicated that an increasing proportion of the population in America is living with several chronic ailments, with 42% reporting two or more and 12% having five or more. Consequently, the escalating demand driven by the widespread incidence of chronic diseases propels the expansion of the drug infusion system market.

Which Segments Form The Key Structure Of The Drug Infusion Systems Market?

The drug infusion systemsmarket covered in this report is segmented –

1) By Product Type: Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump, Implantable Infusion System

2) By Route Of Administration: Intravenous, Subcutaneous, Arterial, Epidural, Other Routes Of Administration

3) By Application: Oncology And Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, Other Applications

4) By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End Users

Subsegments:

1) By Elastomeric Infusion System: Non-Vented Elastomeric Pumps, Vented Elastomeric Pumps

2) By Disposable Infusion System: Disposable Infusion Pumps, IV Sets With Disposable Components

3) By Syringe Infusion System: Manual Syringe Infusion Pumps, Electric Syringe Infusion Pumps

4) By Peristaltic Pump: Single-Channel Peristaltic Pumps, Multi-Channel Peristaltic Pumps

5) By Multi-Channel Pump: Multi-Channel Infusion Pumps For General Use, Multi-Channel Pumps For Specific Therapies

6) By Patient-Controlled Analgesia (PCA) Pump: Electronic PCA Pumps, Mechanical PCA Pumps

7) By Insulin Pump: Continuous Subcutaneous Insulin Infusion (CSII) Pumps, Patch Insulin Pumps

8) By Implantable Infusion System: Implantable Pumps For Chronic Pain, Implantable Pumps For Chemotherapy

What Strategic Shifts And Innovations Are Influencing The Drug Infusion Systems Market?

Major companies involved in the drug infusion systems market are developing advanced technology, such as cloud-based infusion management systems, to enhance patient care, improve accuracy, and streamline the management of infusion therapies. Cloud-based infusion management systems are digital platforms that facilitate the monitoring, administration, and tracking of medication infusions via the cloud. For instance, in June 2023, Eitan Medical, a US-based global leader in advanced infusion therapy and drug delivery solutions, launched Eitan Insights, a new cloud-based infusion management system designed to meet the unique needs of home and specialty infusions. Eitan Insights is designed to provide healthcare professionals with real-time data and analytics, enabling them to monitor patients remotely and adjust treatment plans as needed. This system enhances medication safety by reducing the risk of errors and improving adherence to prescribed protocols.

Which Firms Are Making The Biggest Impact In The Drug Infusion Systems Market?

Major companies operating in the drug infusion systems market include Medtronic plc, Baxter International Inc., ICU Medical Inc., Becton Dickinson and Company, Smiths Group plc, Tandem Diabetes Care Inc., Terumo Corporation, Halyard Health Inc., Insulet Corporation, Zyno Medical Inc., Braun Melsungen AG, Flowonix Medical Inc., IRadimed Corporation, Moog Inc., Debiotech S.A., Fresenius SE & Co. KGaA, Johnson & Johnson, Hospira, Alaris Health Systems Inc., B. Braun Melsungen AG, Disetronic Medical Systems AG, Accu-Chek, Abbott Diabetes Care Inc., Novo Nordisk A/S, Eli Lilly and Company, Sanofi-Aventis, Ypsomed Holding AG, Valeritas Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/drug-infusion-systems-global-market-report

Which Region Is Expected To Lead The Drug Infusion Systems Market In The Next Few Years?

North America was the largest region in the drug infusion systems market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=10703&type=smp

Browse Through More Reports Similar to the Global Drug Infusion Systems Market 2025, By The Business Research Company

Cardiovascular Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report

Dermatology Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report

Gastrointestinal Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795